Skip to main content
. 2022 Dec 23;20:175. doi: 10.1186/s12958-022-01050-w

Table 1.

Baseline clinical characteristics and laboratory variables in women with and without HDP

Variable HDP (n = 14) Non-HDP (n = 132) p Value
Clinical characteristics
 Maternal age (y) * 33.6 ± 4.4 33.6 ± 4.3 0.9
 Family history AHT 4 (28.6%) 58 (43.9%) 0.2
 Parity * 1.71 ± 1.4 1.89 ± 0.9 0.5
 Previous history of GDM 1 (7.1%) 19 (14.4%) 0.4
 Previous history of preeclampsia 1 (7.1%) 2 (1.5%) 0.1
 Gestational age at enrollement (w) * 31.2 ± 1.9 31.1 ± 1.9 0.8
 Pregestational BMI (kg/m2) * 30.1 ± 6.8 26.0 ± 5.0 0.046
 Obesity 8 (57.1%) 28 (21.2%) 0.006
 GDM 11 (78.6%) 67 (50.2%) 0.047
 Insulin treatment 5 (45.4%) 24 (35.8%) 0.2
 Office Systolic BP (mmHg) * 118.5 ± 15.7 109.7 ± 15.4 0.043
 Office Diastolic BP (mmHg) * 74.5 ± 9.7 65.9 ± 9.0 0.001
 ASA prophylaxis 5 (35.7%) 14 (10.6%) 0.008
Laboratory parameters
 Basal glucose (mmol/L) * 4.9 ± 0.5 4.8 ± 0.5 0.039
 HbA1c (%)* 5.2 ± 0.5 4.8 ± 0.3 0.002
 HOMA-IR * 2.9 ± 1.1 2.0 ± 1.3 0.09
 Albumin/creatinine (mg/g) * 28.3 ± 60.0 6.3 ± 6.6 0.1
 Uric acid (mmol/L) * 0.24 ± 0.06 0.22 ± 0.13 0.6
 Total-cholesterol (mmol/L) * 6.52 ± 0.86 6.45 ± 1.19 0.8
 LDL-cholesterol (mmol/L) * 3.76 ± 0.8 3.66 ± 1.22 0.7
 HDL-cholesterol (mmol/L) * 1.99 ± 0.42 1.92 ± 0.47 0.6
 Triglycerides (mmol/L) * 2.2 ± 0.6 2.1 ± 0.8 0.6

* Data expressed as means ± standard deviation; comparisons between different groups were done by the Student’s t– test for parametric variables and the Mann–Whitney U– test for nonparametric variables

Data expressed as n (%); comparisons among groups were done using the χ2 test, or Fisher’s exact test for nonparametric contrasting

HDP hypertensive disorders of pregnancy, AHT arterial hypertension, BMI body mass index, GDM gestational diabetes mellitus, BP blood pressure, ASA acetylsalicylic acid, HbA1c glycated hemoglobin, LDL low-density lipoprotein, HDL high-density lipoprotein